Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. April 5, 2018. Sean Boyd.

Executive Summary

Check out what FDA device compliance officer Sean Boyd had to say about the prospects of applying least-burdensome requirements to inspections and warning-letter close-outs.

"In the case of inspectional interactions, least burdensome approaches could streamline the way we interact and follow-up to an inspection, or when we’re requesting additional information from industry to evaluate and ensure that those findings are remedied, which could impact, for example, warning letter close-outs." – Sean Boyd, deputy director for regulatory affairs, CDRH's Office of Compliance



Click here for a free trial of Medtech Insight

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT122440

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel